D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -95.87% -85.48% -40.94% -63.06% -56.68%
Total Other Revenue -- -- -- -- --
Total Revenue -95.87% -85.48% -40.94% -63.06% -56.68%
Cost of Revenue 29.42% 48.88% 84.38% 39.99% 2.63%
Gross Profit -46.41% -68.83% -104.04% -67.64% -26.02%
SG&A Expenses -53.33% -48.22% -42.09% 121.95% 90.47%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -13.65% -4.47% 9.72% 71.03% 35.05%
Operating Income 8.66% -0.54% -12.70% -91.33% -54.98%
Income Before Tax 8.10% 14.02% 19.17% -67.61% -38.27%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 8.10% 14.02% 19.17% -67.46% -38.15%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 8.10% 14.02% 19.17% -67.46% -38.15%
EBIT 8.66% -0.54% -12.70% -91.33% -54.98%
EBITDA 5.64% -3.89% -11.03% -101.49% -58.07%
EPS Basic 29.86% 40.99% 48.73% -5.16% 8.50%
Normalized Basic EPS 29.81% 40.94% 48.69% -5.07% 8.57%
EPS Diluted 29.86% 40.99% 48.73% -5.16% 8.50%
Normalized Diluted EPS 29.81% 40.94% 48.69% -5.07% 8.57%
Average Basic Shares Outstanding 21.77% 41.13% 67.76% 74.15% 61.52%
Average Diluted Shares Outstanding 21.77% 41.13% 67.76% 74.15% 61.52%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --